U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H16ClNO2S.C6H6O3S
Molecular Weight 479.997
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLOPIDOGREL BESYLATE

SMILES

OS(=O)(=O)C1=CC=CC=C1.COC(=O)[C@@H](N2CCC3=C(C2)C=CS3)C4=CC=CC=C4Cl

InChI

InChIKey=CUZIJKLLBDXNFV-RSAXXLAASA-N
InChI=1S/C16H16ClNO2S.C6H6O3S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;7-10(8,9)6-4-2-1-3-5-6/h2-5,7,9,15H,6,8,10H2,1H3;1-5H,(H,7,8,9)/t15-;/m0./s1

HIDE SMILES / InChI
Molecular Formula C16H16ClNO2S
Molecular Weight 321.822
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED
Molecular Formula C6H6O3S
Molecular Weight 158.175
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:05:09 UTC 2023
Edited
by admin
on Fri Dec 15 18:05:09 UTC 2023
Record UNII
BL9VGG8BHW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLOPIDOGREL BESILATE
EMA EPAR  
Preferred Name English
CLOPIDOGREL BESYLATE
WHO-DD  
Common Name English
CLOPIDOGREL APOTEX
Brand Name English
CLOPIDOGREL BENZENESULFONIC ACID SALT
Common Name English
CLOPIDOGREL ACINO PHARMA GMBH
Brand Name English
CLOPIDOGREL ACINO PHARMA
Brand Name English
CLOPIDOGREL RATIOPHARM GMBH
Brand Name English
CLOPIDOGREL HEXAL
Brand Name English
CLOPIDOGREL ACINO
Brand Name English
GREPID
Brand Name English
CLOPIDOGREL SANDOZ
Brand Name English
CLOPIDOGREL 1A-PHARMA
Brand Name English
Clopidogrel Besylate [WHO-DD]
Common Name English
CLOPIDOGREL BENZENESULFONATE
Common Name English
CLOPIDOGREL BESILATE [EP MONOGRAPH]
Common Name English
THIENO(3,2-C)PYRIDINE-5(4H)-ACETIC ACID, .ALPHA.-(2-CHLOROPHENYL)-6,7-DIHYDRO-, METHYL ESTER, (.ALPHA.S)-, BENZENESULFONATE
Common Name English
CLOPIDOGREL-RATIOPHARM
Brand Name English
CLOPIDOGREL BESILATE [EMA EPAR]
Common Name English
(S)-METHYL-2-(2-CHLOROPHENYL)-2-(6,7-DIHYDROTHIENO(3,2-C)PYRIDIN-5(4H)-YL)ACETATE METHANESULFONATE
Systematic Name English
THIENO(3,2-C)PYRIDINE-5(4H)-ACETIC ACID, .ALPHA.-(2-CHLOROPHENYL)-6,7-DIHYDRO-, METHYL ESTER, (.ALPHA.S)-, BENZENESULFONATE (1:1)
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS CLOPIDOGRAL HEXAL (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL HEXAL (WITHDRAWN: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL RATIOPHARM GMBH (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ACINO (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL RATIOPHARM (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ACINO PHARMA (WITHDRAWN: STROKE)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL SANDOZ (WITHDRAWN: STROKE)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ACINO PHARMA (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL 1A-PHARMA (WITHDRAWN: STROKE)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL SANDOZ (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL 1A PHARMA (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ACINO (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS GREPID (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ACINO PHARMA (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL HEXAL (WITHDRAWN:
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS GREPID (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ACINO (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL APOTEX (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL RATIOPHARM (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL HEXAL (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL APOTEX (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ACINO PHARMA GMBH (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL HEXAL (WITHDRAWN: STROKE)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL 1A PHARMA (WITHDRAWN: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL SANDOZ (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL RATIOPHARM GMBH (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS GREPID (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL 1A PHARMA (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ACINO (AUTHORIZED: STROKE)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL RATIOPHARM GMBH (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ACINO PHARMA GMBH (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL ACINO PHARMA GMBH (WITHDRAWN: STROKE)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL APOTEX (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
Code System Code Type Description
CAS
744256-69-7
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
PRIMARY
DRUG BANK
DBSALT002628
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
PRIMARY
EVMPD
SUB30714
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
PRIMARY
FDA UNII
BL9VGG8BHW
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
PRIMARY
SMS_ID
100000115443
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
PRIMARY
PUBCHEM
9847991
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
PRIMARY
EPA CompTox
DTXSID30225441
Created by admin on Fri Dec 15 18:05:09 UTC 2023 , Edited by admin on Fri Dec 15 18:05:09 UTC 2023
PRIMARY
Related Record Type Details
Structure of CLOPIDOGREL
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of Methyl (αR)-α-(2-chlorophenyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-acetate
IMPURITY -> PARENT
Structure of Methyl α-(2-chlorophenyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-acetate
IMPURITY -> PARENT
Structure of (1R)-1-(2-CHLOROPHENYL)-2-METHOXY-2-OXOETHYL (.ALPHA.S)-.ALPHA.-(2-CHLOROPHENYL)-6,7-DIHYDROTHIENO(3,2-C)PYRIDINE-5(4H)-ACETATE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of METHYL (2S)-2-(2-CHLOROPHENYL)-2-((2-(THIOPHEN-2-YL)ETHYL)AMINO)ACETATE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of CLOPIDOGREL, (R)-
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 2-(2-CHLOROPHENYL)-2-(6,7-DIHYDROTHIENO(3,2-C)PYRIDIN-5(4H)-YL)ACETAMIDE, (±)-
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of Methyl (αS)-α-(2-chlorophenyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-acetate
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of CLOPIDOGREL CARBOXYLIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
Structure of CLOPIDOGREL
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966